Generated by AI
Summary of Jul 24's posts. Generated by AI.
Summary of Feb 5's posts. Generated by AI.
No summary yet.
Summary of Feb 5's posts. Generated by AI.
Investors talking about GDTC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
CytoMed Therapeutics Ltd. is a Singapore-based biopharmaceutical company focused on developing cell-based immunotherapies for cancer and other serious diseases. Its current pipeline centers on innate immune cell and stem cell-based technologies, including gamma delta T-cell, natural killer T-cell, and pluripotent stem cell platforms designed to support novel therapeutic candidates. The company’s work includes research, development, processing, and banking of cells, with an emphasis on allogeneic approaches that use donor-derived materials. CytoMed Therapeutics Ltd. operates primarily in Singapore and Malaysia, serving the growing biotechnology and advanced therapy markets in Asia. Its role in the financial market is tied to the high-potential but research-intensive biopharmaceutical sector, where progress depends on clinical development, regulatory milestones, and platform innovation.
Website1 Commonwealth Lane
Singapore, 149544
Singapore
The latest articles about GDTC.
Detailed price information for Roche Holding Div RTS (RHHVF) from The Globe and Mail including charting and trades.